Phoenix Biotech Acquisition Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Phoenix Biotech Acqu recent Real Value cannot be determined due to lack of data. The prevailing price of Phoenix Biotech Acqu is $0.0. Our model determines the value of Phoenix Biotech Acqu from analyzing the company fundamentals such as Shares Owned By Insiders of 95.20 %, return on asset of -0.0255, and Number Of Shares Shorted of 757 as well as examining its technical indicators and probability of bankruptcy.
Phoenix Biotech Total Value Analysis
Phoenix Biotech Acquisition is at this time forecasted to have valuation of 36.13 M with market capitalization of 34.85 M, debt of 650 K, and cash on hands of 553.77 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Phoenix Biotech fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
36.13 M | 34.85 M | 650 K | 553.77 K |
Phoenix Biotech Asset Utilization
One of the ways to look at asset utilization of Phoenix is to check how much profit was generated for every dollar of assets it reports. Phoenix Biotech holds a negative application of assets of -0.0255 pct., losing $2.55E-4 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Phoenix Biotech Acquisition shows how discouraging it operates for each dollar spent on its assets.Phoenix Biotech Ownership Allocation
The market capitalization of Phoenix Biotech Acqu is $34.85 Million. Phoenix Biotech holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 95.2 pct. of Phoenix Biotech Acqu outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that almost six hundred thirty thousand nine hundred thirty-nine invesors are currently shorting Phoenix Biotech expressing very little confidence in its future performance.Phoenix Biotech Profitability Analysis
Net Loss for the year was (2.52 M) with profit before overhead, payroll, taxes, and interest of 0.Phoenix Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 17.9 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |